Bath & Body Works (NYSE:BBWI) Trading Down 4.3% – Here’s What Happened

Bath & Body Works, Inc. (NYSE:BBWI) shares traded down 4.3% during trading on Monday . The stock traded as low as $25.45 and last traded at $25.52. 1,634,793 shares were traded during trading, a decline of 70% from the average session volume of 5,442,269 shares. The stock had previously closed at $26.66.

Analysts Set New Price Targets

Several research analysts have recently commented on the stock. Citigroup dropped their price target on shares of Bath & Body Works from $42.00 to $40.00 and set a “buy” rating on the stock in a research note on Tuesday, August 19th. Wall Street Zen downgraded shares of Bath & Body Works from a “buy” rating to a “hold” rating in a report on Saturday, August 9th. UBS Group decreased their price objective on shares of Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating for the company in a report on Friday, August 29th. Barclays upped their price objective on shares of Bath & Body Works from $30.00 to $32.00 and gave the stock an “equal weight” rating in a report on Friday, August 29th. Finally, JPMorgan Chase & Co. upped their price objective on shares of Bath & Body Works from $40.00 to $46.00 and gave the stock an “overweight” rating in a report on Monday, July 28th. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $39.69.

Bath & Body Works Trading Down 2.7%

The business’s fifty day simple moving average is $29.07 and its two-hundred day simple moving average is $29.61. The stock has a market capitalization of $5.35 billion, a P/E ratio of 7.70, a P/E/G ratio of 0.91 and a beta of 1.49.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings data on Thursday, August 28th. The company reported $0.37 EPS for the quarter, hitting analysts’ consensus estimates of $0.37. The company had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.55 billion. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The firm’s revenue for the quarter was down .8% compared to the same quarter last year. During the same period last year, the firm earned $0.37 EPS. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, equities research analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 5th. Stockholders of record on Friday, August 22nd were issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.1%. The ex-dividend date of this dividend was Friday, August 22nd. Bath & Body Works’s dividend payout ratio (DPR) is presently 23.74%.

Hedge Funds Weigh In On Bath & Body Works

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. T. Rowe Price Investment Management Inc. lifted its holdings in shares of Bath & Body Works by 7.6% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 11,016,767 shares of the company’s stock worth $334,029,000 after acquiring an additional 781,681 shares during the period. JPMorgan Chase & Co. lifted its holdings in Bath & Body Works by 11.5% during the 2nd quarter. JPMorgan Chase & Co. now owns 7,080,106 shares of the company’s stock valued at $212,120,000 after purchasing an additional 733,000 shares during the last quarter. Victory Capital Management Inc. lifted its holdings in Bath & Body Works by 14,732.0% during the 1st quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company’s stock valued at $206,119,000 after purchasing an additional 6,752,274 shares during the last quarter. Alliancebernstein L.P. lifted its holdings in Bath & Body Works by 5.8% during the 2nd quarter. Alliancebernstein L.P. now owns 5,737,796 shares of the company’s stock valued at $171,904,000 after purchasing an additional 315,738 shares during the last quarter. Finally, Cooper Creek Partners Management LLC lifted its holdings in Bath & Body Works by 42.7% during the 2nd quarter. Cooper Creek Partners Management LLC now owns 5,409,919 shares of the company’s stock valued at $162,081,000 after purchasing an additional 1,619,276 shares during the last quarter. 95.14% of the stock is owned by institutional investors.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.